Lexaria Bioscience Corp. (LEXX)
Lexaria Bioscience Market Cap : 14.68M for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CannaPharmaRx, Inc. | 2.036M |
| InMed Pharmaceuticals, Inc. | 2.121M |
| Target Group, Inc. (Canada) | 1.111M |
| Tilray Brands, Inc. | 617.12M |
| NervGen Pharma Corp. | 288.52M |
Market Cap Related Metrics
| PS Ratio | 33.66 |
| Price to Book Value | 2.223 |
| Price | 0.5922 |
| Earnings Yield | -80.85% |